EcoDrugPlus

Ribosomal Protein L13

Ensembl ID : ENSPVAG00000015130
Gene Symbol: RPL13
1 Cross references
268 Possible Orthologues:

Ribosomal Protein L13a

Ensembl ID : ENSPVAG00000010958
Gene Symbol: RPL13A
1 Cross references
280 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSPVAG00000013914
Gene Symbol: RPL14
1 Cross references
259 Possible Orthologues:

Ribosomal Protein L17

Ensembl ID : ENSPVAG00000001969
Gene Symbol: RPL17
1 Cross references
700 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSPVAG00000009524
Gene Symbol: RPL18
1 Cross references
321 Possible Orthologues:

Ribosomal Protein L18a

Ensembl ID : ENSPVAG00000017378
Gene Symbol: RPL18A
1 Cross references
178 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSPVAG00000008498
Gene Symbol: RPL19
1 Cross references
239 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSPVAG00000009773
Gene Symbol: RPL22
1 Cross references
90 Possible Orthologues:

Ribosomal Protein L23

Ensembl ID : ENSPVAG00000002277
Gene Symbol: RPL23
1 Cross references
233 Possible Orthologues:

Ribosomal Protein L23a

Ensembl ID : ENSPVAG00000002922
Gene Symbol: RPL23A
1 Cross references
72 Possible Orthologues:

Ribosomal Protein L24

Ensembl ID : ENSPVAG00000009889
Gene Symbol: RPL24
1 Cross references
302 Possible Orthologues:

Ribosomal Protein L27

Ensembl ID : ENSPVAG00000008817
Gene Symbol: RPL27
1 Cross references
215 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).